Regional survey of CTX-M-type extended-spectrum β-lactamases among Enterobacteriaceae reveals marked heterogeneity in the distribution of the ST131 clone

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 3, 2011, Pages 505-511

  Xu, Li ^a,b   Shabir, Sahida ^a   Bodah, Thomas ^a   McMurray, Claire ^a,b   Hardy, Katie ^a,b   Hawkey, Peter ^a,b   Nye, Kathryn ^a  

^a UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

ESBLs; Molecular epidemiology; O25b ST131

Indexed keywords

BETA LACTAMASE CTX M; CIPROFLOXACIN; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; TRIMETHOPRIM;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ENTEROBACTERIACEAE; ESCHERICHIA COLI; GENOTYPE; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; PROTEIN EXPRESSION; SCREENING; UNITED KINGDOM;

BACTERIAL TYPING TECHNIQUES; BETA-LACTAMASES; DNA, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; GREAT BRITAIN; HUMANS; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; NUCLEIC ACID DENATURATION; POLYMERASE CHAIN REACTION; PREVALENCE;

EID: 79951521378     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkq482     Document Type: Article

References (24)

1. Woodford N, Ward ME, Kaufmann ME et al. Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum β-lactamases in the UK. J Antimicrob Chemother 2004; 54: 735-43.
2. CTX-M genes by multiplex PCR assay. J Med Microbiol 2005; 54: 1183-7.
3. Xu L, Evans J, Ling T et al. Rapid genotyping of CTX-M extended-spectrum β-lactamases by denaturing high-performance liquid chromatography. Antimicrob Agents Chemother 2007; 51: 1446-54.
4. Clermont O, Dhanji H, Upton M et al. Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains. J Antimicrob Chemother 2009; 64: 274-7.
5. Livermore DM, Hawkey PM. CTX-M: changing the face of ESBLs in the UK. J Antimicrob Chemother 2005; 56: 451-4.
6. Potz NA, Hope R, Warner M et al. Prevalence and mechanisms of cephalosporin resistance in Enterobacteriaceae in London and South-East England. J Antimicrob Chemother 2006; 58: 320-6.
7. Morris D, Boyle F, Buckley V et al. CTX-M enzymes are the predominant extended-spectrum β-lactamases produced by Enterobacteriaceae in Ireland. J Antimicrob Chemother 2009; 64: 864-6.
8. Yu Y, Ji S, Chen Y et al. Resistance of strains producing extended-spectrum β-lactamases and genotype distribution in China. J Infect 2007; 54: 53-7.
9. Blanco M, Alonso MP, Nicolas-Chanoine MH et al. Molecular epidemiology of Escherichia coli producing extended-spectrum β-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15. J Antimicrob Chemother 2009; 63: 1135-41.
10. Arpin C, Quentin C, Grobost F et al. Nationwide survey of extended-spectrum β-lactamase-producing Enterobacteriaceae in the French community setting. J Antimicrob Chemother 2009; 63: 1205-14.
11. Kiratisin P, Apisarnthanarak A, Laesripa C et al. Molecular characterization and epidemiology of extended-spectrum-β-lactamaseproducing Escherichia coli and Klebsiella pneumoniae isolates causing health care-associated infection in Thailand, where the CTX-M family is endemic. Antimicrob Agents Chemother 2008; 52: 2818-24.
12. Brigante G, Luzzaro F, Perilli M et al. Evolution of CTX-M-type β-lactamases in isolates of Escherichia coli infecting hospital and community patients. Int J Antimicrob Agents 2005; 25: 157-62.
13. Hernandez JR, Martinez-Martinez L, Canton R et al. Nationwide study of Escherichia coli and Klebsiella pneumoniae producing extended-spectrum β-lactamases in Spain. Antimicrob Agents Chemother 2005; 49: 2122-5.
14. Villegas MV, Kattan JN, Quinteros MG et al. Prevalence of extended-spectrum β-lactamases in South America. Clin Microbiol Infect 2008; 14 Suppl 1: 154-8.
15. Liu W, Chen L, Li H et al. Novel CTX-M β-lactamase genotype distribution and spread into multiple species of Enterobacteriaceae in Changsha, Southern China. J Antimicrob Chemother 2009; 63: 895-900.
16. Nicolas-Chanoine MH, Blanco J, Leflon-Guibout V et al. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother 2008; 61: 273-81.
17. Coque TM, Novais A, Carattoli A et al. Dissemination of clonally related Escherichia coli strains expressing extended-spectrum β-lactamase CTX-M-15. Emerg Infect Dis 2008; 14: 195-200.
18. Hawkey PM, Jones AM. The changing epidemiology of resistance. J Antimicrob Chemother 2009; 64 Suppl 1: i3-10.
19. Hawkey PM. Prevalence and clonality of extended-spectrum β-lactamases in Asia. Clin Microbiol Infect 2008; 14 Suppl 1: 159-65.
20. Lau SH, Kaufmann ME, Livermore DM et al. UK epidemic Escherichia coli strains A-E, with CTX-M-15 β-lactamase, all belong to the international O25:H4-ST131 clone. J Antimicrob Chemother 2008; 62: 1241-4.
21. Ensor VM, Shahid M, Evans JT et al. Occurrence, prevalence and genetic environment of CTX-M β-lactamases in Enterobacteriaceae from Indian hospitals. J Antimicrob Chemother 2006; 58: 1260-3.
22. Pitout JD, Gregson DB, Campbell L et al. Molecular characteristics of extended-spectrum-β-lactamase-producing Escherichia coli isolates causing bacteremia in the Calgary Health Region from 2000 to 2007: emergence of clone ST131 as a cause of community-acquired infections. Antimicrob Agents Chemother 2009; 53: 2846-51.
23. Johnson JR, Menard M, Johnston B et al. Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004. Antimicrob Agents Chemother 2009; 53: 2733-9.
24. Brenwald NP, Jevons G, Andrews JM et al. An outbreak of a CTX-M-type β-lactamase-producing Klebsiella pneumoniae: the importance of using cefpodoxime to detect extended-spectrum β-lactamases. J Antimicrob Chemother 2003; 51: 195-6.